UL licenses new optical fibre technology to Pointec Medical

NewsGuard 100/100 Score

The University of Limerick (UL) recently licensed a ground breaking new technology based on optical fibres to the Galway based medical devices company, Pointec Medical Ltd. The technology can be used to better inform physicians on the appropriate intervention for vascular disorders such as coronary artery stenosis (narrowing of the arteries). Developed by UL researchers, the optical fibre technology is thin enough to be threaded through the arteries of the human body and can take pressure and temperature readings within the arteries themselves. 

UL licenses optical fibre pressure sensing technology which will be used to improve detection of coronary blockages.

Somewhat similar devices are currently used to perform a procedure called Fractional Flow Reserve diagnostics, in order to assess whether it is appropriate to implant a stent or to treat arterial blockages through other means. However, many of the currently available technologies, which are used in this procedure, have potential limitations in terms of their accuracy and stability.

The patent pending technology has already undergone significant evaluation testing at labs in Ireland and North America. The estimated market value for this pressure wire technology is €200 million a year and growing at a rate of 40% per year. 

Co- inventor, Dr. Gabriel Leen said; “The fibre optic based temperature and pressure sensor technology has the potential to significantly improve the quality of coronary diagnostics and provide cardiac surgeons with a powerful tool to accurately assess the level of arterial blockages in order to determine the most appropriate treatment for patients.”

Company director, Alan Crean, Pointec Medical Ltd. said; "We are delighted to be able to work with the team of researchers in UL who have developed a great technology with a huge market potential".

"We are very pleased to be in a position to partner with a company like Pointec Medical Ltd." said Paul Dillon, Technology Transfer Director, UL, "we are very keen to see our research have an impact in the marketplace." In the past 5 years UL research has resulted in 107 new inventions, 34 patent applications, 31 commercialisation agreements with industry and seven new spin-out companies. UL continues to one of the top Irish universities in translating research investment into marketable product and services.

The optical fibre pressure and temperature sensor technology was developed at the Optical Fibre Sensor Research Centre (www.ofsrc.ul.ie), University of Limerick by a research team led by Professor Elfed Lewis in collaboration Hochschule Wismar, University of Applied Sciences, Germany.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors